Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2492898rdf:typepubmed:Citationlld:pubmed
pubmed-article:2492898lifeskim:mentionsumls-concept:C0007137lld:lifeskim
pubmed-article:2492898lifeskim:mentionsumls-concept:C0460004lld:lifeskim
pubmed-article:2492898lifeskim:mentionsumls-concept:C0205462lld:lifeskim
pubmed-article:2492898lifeskim:mentionsumls-concept:C0441800lld:lifeskim
pubmed-article:2492898lifeskim:mentionsumls-concept:C0445204lld:lifeskim
pubmed-article:2492898lifeskim:mentionsumls-concept:C1718423lld:lifeskim
pubmed-article:2492898pubmed:issue6lld:pubmed
pubmed-article:2492898pubmed:dateCreated1989-4-5lld:pubmed
pubmed-article:2492898pubmed:abstractTextForty-one patients with Stage III and IV squamous cell carcinomas (SCC) of the head and neck were treated preoperatively with mitomycin C and 5-fluorouracil and concomitant radiotherapy. Operation specimen were examined histologically, the percentage of vital tumor cells and devitalized tumor cells were graduated. The grade of regression was classified according to a four-stage scale. Tumor regression was elevated as good (Grades 1, 2) and bad (3, 4) response to combined preoperative therapy. After a follow-up of 18 to 30 months, 14 of 41 patients have experienced a locoregional recurrence; all these patients were bad responders (Grades 3, 4) to preoperative radiochemotherapy. There was a statistically significant correlation between tumor regression grade and probability of survival (P less than 0.001). The authors conclude that the prognosis of patients with pretreated SCC of head and neck depends on the histologic grade of tumor regression.lld:pubmed
pubmed-article:2492898pubmed:languageenglld:pubmed
pubmed-article:2492898pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2492898pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2492898pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2492898pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2492898pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2492898pubmed:statusMEDLINElld:pubmed
pubmed-article:2492898pubmed:monthMarlld:pubmed
pubmed-article:2492898pubmed:issn0008-543Xlld:pubmed
pubmed-article:2492898pubmed:authorpubmed-author:PoppWWlld:pubmed
pubmed-article:2492898pubmed:authorpubmed-author:ScherrerRRlld:pubmed
pubmed-article:2492898pubmed:authorpubmed-author:KrischKKlld:pubmed
pubmed-article:2492898pubmed:authorpubmed-author:StrasslHHlld:pubmed
pubmed-article:2492898pubmed:authorpubmed-author:HolznerJ HJHlld:pubmed
pubmed-article:2492898pubmed:authorpubmed-author:NeumeisterBBlld:pubmed
pubmed-article:2492898pubmed:authorpubmed-author:DobrowskyWWlld:pubmed
pubmed-article:2492898pubmed:authorpubmed-author:DobrowskyEElld:pubmed
pubmed-article:2492898pubmed:authorpubmed-author:BraunO MOMlld:pubmed
pubmed-article:2492898pubmed:authorpubmed-author:RauschE MEMlld:pubmed
pubmed-article:2492898pubmed:issnTypePrintlld:pubmed
pubmed-article:2492898pubmed:day15lld:pubmed
pubmed-article:2492898pubmed:volume63lld:pubmed
pubmed-article:2492898pubmed:ownerNLMlld:pubmed
pubmed-article:2492898pubmed:authorsCompleteYlld:pubmed
pubmed-article:2492898pubmed:pagination1097-100lld:pubmed
pubmed-article:2492898pubmed:dateRevised2006-4-24lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:meshHeadingpubmed-meshheading:2492898-...lld:pubmed
pubmed-article:2492898pubmed:year1989lld:pubmed
pubmed-article:2492898pubmed:articleTitleHistologic tumor regression grades in squamous cell carcinoma of the head and neck after preoperative radiochemotherapy.lld:pubmed
pubmed-article:2492898pubmed:affiliationDepartment of Pathology, University of Vienna, Austria.lld:pubmed
pubmed-article:2492898pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2492898lld:pubmed